What’s New in Diabetic Retinopathy and Venous Occlusive Disease?
10/27/2017 12:00 am
Johns Hopkins School of Medicine
720 Rutland Avenue
Save to your calendar
The total number of people worldwide with diabetes mellitus is projected to rise from 171 million in 2000 to 366 million in 2030. In the United States, almost 24 million or 8 percent of the population has diabetes mellitus. Approximately 4.0 million Americans age 40 and older have diabetic retinopathy, 900,000 of whom have vision threatening disease, defined as pre-proliferative retinopathy, macular edema, or both. Diabetic retinopathy remains the leading cause of blindness in adults who make up the work force. Despite this, diabetic retinopathy and venous occlusive disease are often under-diagnosed and under-treated. This annual course highlights new information being reported by the Diabetic Retinopathy Clinical Research Network and others, which will impact current standard care and management strategies.
Contact Name: Kimberly Butler
Website URL: https://hopkinscme.cloud-cme.com/aph.aspx?P=5&EID=10728